ENTRY       D12586            Mixture   Drug
NAME        Mifepristone and misoprostol;
            Mefeego (TN)
COMPONENT   Mifepristone [DR:D00585], Misoprostol [DR:D00419]
CLASS       Metabolizing enzyme substrate
             DG01633  CYP3A/CYP3A4 substrate
            Metabolizing enzyme inhibitor
             DG02852  CYP3A/CYP3A4 inhibitor
REMARK      Therapeutic category: 2499
            ATC code: G03XB51
            Product: D12586<JP>
EFFICACY    Abortifacient
COMMENT     Mifepristone is a substrate and an inhibitor of CYP3A.
METABOLISM  Enzyme: CYP3A [HSA:1576 1577 1551]
INTERACTION CYP inhibition: CYP3A [HSA:1576 1577 1551]
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             G GENITO URINARY SYSTEM AND SEX HORMONES
              G03 SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM
               G03X OTHER SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM
                G03XB Progesterone receptor modulators
                 G03XB51 Mifepristone, combinations
                  D12586  Mifepristone and misoprostol &lt;JP&gt;
            Therapeutic category of drugs in Japan [BR:br08301]
             2  Agents affecting individual organs
              24  Hormones
               249  Miscellaneous
                2499  Others
                 D12586  Mifepristone and misoprostol
            Drug groups [BR:br08330]
             Metabolizing enzyme substrate
              DG01633  CYP3A/CYP3A4 substrate
               D12586  Mifepristone and misoprostol
             Metabolizing enzyme inhibitor
              DG02852  CYP3A/CYP3A4 inhibitor
               D12586  Mifepristone and misoprostol
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D12586
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D12586
///
